SCHEMBL95039

SCHEMBL95039

c1ccc2c(c1)CN(c1ccc(Oc3ccc(N4COc5ccccc5C4)cc3)cc1)CO2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
BACE1 P56817 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LTA4H P09960 4/20 0.41
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.37
MGLL Q99685 1/20 0.33
LMNA P02545 2/20 0.33
OXTR P30559 1/20 0.33
VDR P11473 1/20 0.32
FFAR1 O14842 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
CYP19A1 P11511 1/20 0.32
HSD17B3 P37058 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13203360 1.00 NPC1 (0.44) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL15358724 0.95 NPC1 (0.41) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL15358747 0.93 LTA4H (0.40) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL19404937 0.93 RAB9A (0.39) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL10002046 0.93 NPC1 (0.42) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL18328646 0.92 NPC1 (0.41) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL15358767 0.92 FFAR1 (0.41) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL13203347 0.92 NPC1 (0.38) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL29579877 0.92 FFAR1 (0.41) NPC1RAB9AMAPTALDH1A1TP53
SCHEMBL20932611 0.90 MEN1 (0.47) NPC1RAB9AMAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441833-B2 Composition for curable resin, cured product of said composition, production method for said composition and said cured product, and semiconductor device ENEOS CORPORATION (JP) 2025-10-14 US disclosed
US-20240132701-A1 COMPOSITION FOR CURABLE RESINS, CURED PRODUCT OF SAID COMPOSITION, METHOD FOR PRODUCING SAID COMPOSITION, METHOD FOR PRODUCING SAID CURED PRODUCT, AND SEMICONDUCTOR DEVICE ENEOS CORPORATION (JP) 2024-04-25 US disclosed
EP-4289882-A1 COMPOSITION FOR CURABLE RESINS, CURED PRODUCT OF SAID COMPOSITION, METHOD FOR PRODUCING SAID COMPOSITION, METHOD FOR PRODUCING SAID CURED PRODUCT, AND SEMICONDUCTOR DEVICE ENEOS Corporation (JP) 2023-12-13 EP disclosed
EP-3553129-B1 CURING RESIN COMPOSITION, CURED PRODUCT OF, AND CURING METHOD FOR, CURING RESIN COMPOSITION, AND SEMICONDUCTOR DEVICE ENEOS CORP (JP) 2023-11-22 EP disclosed
EP-3450499-B1 COMPOSITION FOR CURABLE RESIN, AND CURED PRODUCT THEREOF ENEOS CORP (JP) 2023-11-01 EP disclosed
US-11584824-B2 Composition for curable resin, cured product of said composition, production method for said composition and said cured product, and semiconductor device ENEOS CORPORATION (JP) 2023-02-21 US disclosed
US-11578166-B2 Composition for curable resin, cured product of said composition, production method for said composition and said cured product, and semiconductor device ENEOS CORPORATION (JP) 2023-02-14 US disclosed
US-11560465-B2 Composition for curable resin, cured product of said composition, method of producing said composition and said cured product, and semiconductor device ENEOS CORPORATION (JP) 2023-01-24 US disclosed
US-20220389130-A1 FILM, LAMINATE, SEMICONDUCTOR WAFER WITH FILM LAYER, SUBSTRATE FOR MOUNTING SEMICONDUCTOR WITH FILM LAYER, AND SEMICONDUCTOR DEVICE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-12-08 US disclosed
WO-2022168815-A1 COMPOSITION FOR CURABLE RESINS, CURED PRODUCT OF SAID COMPOSITION, METHOD FOR PRODUCING SAID COMPOSITION, METHOD FOR PRODUCING SAID CURED PRODUCT, AND SEMICONDUCTOR DEVICE ENEOS株式会社 2022-08-11 WO disclosed
US-20150119522-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC CORPORATION (JP) 2015-04-30 US disclosed
US-20150105503-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC PETROCHEMICAL CORPORATION (JP) 2015-04-16 US disclosed
US-20150105503-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC PETROCHEMICAL CORPORATION (JP) 2015-04-16 US disclosed
US-8580916-B2 Stable solution of the polymer prepared from N,O-heterocycles and its preparation method and use TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2013-11-12 US disclosed
US-8580916-B2 Stable solution of the polymer prepared from N,O-heterocycles and its preparation method and use TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2013-11-12 US disclosed
WO-2013161569-A1 LIQUID-CRYSTAL-ORIENTING AGENT FOR FORMING LIQUID-CRYSTAL-ORIENTED FILM FOR PHOTOALIGNMENT, LIQUID-CRYSTAL-ORIENTED FILM, AND LIQUID-CRYSTAL DISPLAY ELEMENT USING LIQUID-CRYSTAL-ORIENTED FILM JNC株式会社 (JP) 2013-10-31 WO disclosed
US-20130217820-A1 BENZOXAZINE-SYSTEM COMPOSITION, AND THERMOSETTING MATERIAL AND VARNISH THEREOF JFE CHEMICAL CORPORATION (JP) 2013-08-22 US disclosed
US-20130217820-A1 BENZOXAZINE-SYSTEM COMPOSITION, AND THERMOSETTING MATERIAL AND VARNISH THEREOF JFE CHEMICAL CORPORATION (JP) 2013-08-22 US disclosed
US-20120059096-A1 Stable Solution of the Polymer Prepared from N,O-Heterocycles and its Preparation Method and Use TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2012-03-08 US disclosed
US-20120059096-A1 Stable Solution of the Polymer Prepared from N,O-Heterocycles and its Preparation Method and Use TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578166-B2 Composition for curable resin, cured product of said composition, production method for said composition and said cured product, and semiconductor device SEM1, SMARCA1, SMARCD2 NPC1 4513/4885RAB9A 4332/4885MAPT 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.